A Fourth Booster May be Needed to Fight the Latest COVID Variant
COVID-19's latest variant, omicron, could increase the chance that folks will need a fourth vaccine dose earlier than expected, according to executives at Pfizer.
COVID-19's latest variant, omicron, could increase the chance that folks will need a fourth vaccine dose earlier than expected, according to executives at Pfizer.
In a report by The Washington Post, Pfizer claimed early lab experiments suggest the standard two-dose regimen remains provides some protection against severe illness from the variant, and boosters are likely to control it.
Executives of Pfizer have said a fourth and necessary dose could be needed at least a year after a third, however more recently it's been said it could be sooner.
It's been stated by the CDC and the WHO, more than 40 people in the U.S. have tested positive for the omicron variant and that the variant has been Most showed mild reported in 57 countries so far.
Pfizer and BioNTech have been working on an Omicron-specific vaccine they hope to have available by March 2022 if the variant becomes widespread. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
